These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17462602)

  • 1. A novel peptide-nucleotide dual vaccine of human telomerase reverse transcriptase induces a potent cytotoxic T-cell response in vivo.
    Guo H; Hao J; Wu C; Shi Y; Zhao XY; Fang DC
    Biochem Biophys Res Commun; 2007 Jun; 357(4):1090-5. PubMed ID: 17462602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses.
    Adotévi O; Mollier K; Neuveut C; Cardinaud S; Boulanger E; Mignen B; Fridman WH; Zanetti M; Charneau P; Tartour E; Lemonnier F; Langlade-Demoyen P
    Clin Cancer Res; 2006 May; 12(10):3158-67. PubMed ID: 16707616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice.
    Rusakiewicz S; Dosset M; Mollier K; Souque P; Charneau P; Wain-Hobson S; Langlade-Demoyen P; Adotévi O
    Vaccine; 2010 Aug; 28(38):6374-81. PubMed ID: 20654669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
    Dupont J; Latouche JB; Ma C; Sadelain M
    Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors.
    Frolkis M; Fischer MB; Wang Z; Lebkowski JS; Chiu CP; Majumdar AS
    Cancer Gene Ther; 2003 Mar; 10(3):239-49. PubMed ID: 12637945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Marukawa Y; Arai K; Yamashita T; Tsuji H; Kuzushima K; Takiguchi M; Kaneko S
    Hepatology; 2006 Jun; 43(6):1284-94. PubMed ID: 16729333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus.
    Chen L; Liang GP; Tang XD; Chen T; Cai YG; Fang DC; Yu ST; Luo YH; Yang SM
    Biochem Biophys Res Commun; 2006 Dec; 351(4):927-34. PubMed ID: 17097054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
    Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice.
    Chen L; Tang XD; Yu ST; Ai ZH; Fang DC; Cai YG; Luo YH; Liang GP; Yang SM
    J Pathol; 2009 Apr; 217(5):685-92. PubMed ID: 19142972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uses of telomerase peptides in anti-tumor immune therapy.
    Li H; Katik I; Liu JP
    Methods Mol Biol; 2007; 405():61-86. PubMed ID: 18369818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.
    Kokhaei P; Palma M; Hansson L; Osterborg A; Mellstedt H; Choudhury A
    Exp Hematol; 2007 Feb; 35(2):297-304. PubMed ID: 17258078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T-cell immunity against telomerase reverse transcriptase in colorectal cancer patients.
    Titu LV; Loveday RL; Madden LA; Cawkwell L; Monson JR; Greenman J
    Oncol Rep; 2004 Oct; 12(4):871-6. PubMed ID: 15375515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro quantification of the cytotoxic T lymphocyte response against human telomerase reverse transcriptase in breast cancer.
    Amarnath SM; Dyer CE; Ramesh A; Iwuagwu O; Drew PJ; Greenman J
    Int J Oncol; 2004 Jul; 25(1):211-7. PubMed ID: 15202008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A preliminary study on anti-liver cancer immunity of the virus-like particulate peptide-nucleic acid vaccine].
    Guo H; Hao J; Wu C; Fang DC
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):272-6. PubMed ID: 16635296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenicity and immunogenicity of peptide analogues of a low affinity peptide of the human telomerase reverse transcriptase tumor antigen.
    Hernández J; Schoeder K; Blondelle SE; Pons FG; Lone YC; Simora A; Langlade-Demoyen P; Wilson DB; Zanetti M
    Eur J Immunol; 2004 Aug; 34(8):2331-41. PubMed ID: 15259031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with truncated sequence of Telomerase Reverse Transcriptase induces a specific antitumor response in vivo.
    Qiu J; Li GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W
    Acta Oncol; 2007; 46(7):961-8. PubMed ID: 17917827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli-nitroreductase suicide gene control of human telomerase reverse transcriptase-transduced minor histocompatibility antigen-specific cytotoxic T cells.
    Verdijk RM; Wilke M; Beslier V; Kloosterman A; Brand A; Goulmy E; Mutis T
    Bone Marrow Transplant; 2004 May; 33(9):963-7. PubMed ID: 15048139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel DNA/peptide combined vaccine induces PSCA-specific cytotoxic T-lymphocyte responses and suppresses tumor growth in experimental prostate cancer.
    Zhang KQ; Yang F; Ye J; Jiang M; Liu Y; Jin FS; Wu YZ
    Urology; 2012 Jun; 79(6):1410.e7-13. PubMed ID: 22513035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenicity of the hTERT540-548 peptide in cancer.
    Wenandy L; Sørensen RB; Sengeløv L; Svane IM; thor Straten P; Andersen MH
    Clin Cancer Res; 2008 Jan; 14(1):4-7. PubMed ID: 18172245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human telomerase reverse transcriptase as a novel target for tumor immunotherapy].
    Pang JX
    Ai Zheng; 2003 Aug; 22(8):893-5. PubMed ID: 12917043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.